A complete application in a minute
Tailored resume and cover letter, ready to send.
Servier's R&D Institute at Paris-Saclay invites a postdoctoral researcher to investigate how colorectal cancer cells resist immune cytokine pressure and to identify approaches to enhance cytokine-induced tumor-cell killing. The project combines mechanistic biology, functional genomics and translational cancer models.
You will design and execute in vitro and in vivo experiments, review literature, present data, manage priorities, and collaborate within the Immuno-Oncology portfolio.
We are a global and independent mid-sized pharmaceutical group governed by a Foundation. Our unique model makes us proud and, more importantly, enables us to fully serve our mission: "committed to therapeutic progress for the benefit of patients."
As a global leader in cardiology, we aim to become a focused and innovative player in oncology by 2030, targeting hard-to-treat cancers and dedicating more than 70% of our R&D budget to this goal.
Who are we? 20,000 passionate individuals from over 50 nationalities, driven by an entrepreneurial spirit. Every day, we move forward with and for patients, with and for our teams, motivated by the desire to care, to dare, to grow, and to commit to being useful to those in need.
Come and experience and contribute to our commitment #MovedByYou.
www.servier.com
At the heart of one of the world's top eight innovation clusters, the Servier R&D Institute at Paris-Saclay is where visionary science meets a powerful global ecosystem. By uniting our Group's innovation potential with this prestigious center of excellence, we are not only accelerating the future of therapeutic discovery but also championing the global influence of French research.
This three-year postdoctoral position will investigate the mechanisms by which colorectal cancer cells resist immune cytokine pressure and identify approaches to enhance cytokine-induced tumor-cell killing. The project combines mechanistic biology, functional genomics and translational cancer models to characterize sensitivity and resistance mechanisms in IFN/TNF signaling and cell-death pathways, and to generate therapeutic and biomarker hypotheses with translational potential.
Our standard recruitment journey includes the following steps:
At one stage of the process, we would be delighted to welcome you to our site to meet in person and share the environment where we work every day to transform patients' lives!
Please note that this recruitment process may be adapted based on the specific requirements of the position.
We are committed to equal opportunities and developing talents in all their diversity. We value both experience and the desire to engage daily in contributing to therapeutic progress for the benefit of patients. If this offer resonates with you, seize this opportunity to meet us!